These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10323210)

  • 1. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.
    Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF
    Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci.
    Brandt ER; Hayman WA; Currie B; Carapetis J; Wood Y; Jackson DC; Cooper J; Melrose WD; Saul AJ; Good MF
    Immunology; 1996 Nov; 89(3):331-7. PubMed ID: 8958044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.
    Hayman WA; Brandt ER; Relf WA; Cooper J; Saul A; Good MF
    Int Immunol; 1997 Nov; 9(11):1723-33. PubMed ID: 9418133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci.
    Brandt ER; Hayman WA; Currie B; Pruksakorn S; Good MF
    Vaccine; 1997 Nov; 15(16):1805-12. PubMed ID: 9364687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.
    Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF
    Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations.
    Brandt ER; Yarwood PJ; McMillan DJ; Vohra H; Currie B; Mammo L; Pruksakorn S; Saour J; Good MF
    Int Immunol; 2001 Oct; 13(10):1335-43. PubMed ID: 11581178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.
    Brandt ER; Teh T; Relf WA; Hobb RI; Good MF
    Infect Immun; 2000 Dec; 68(12):6587-94. PubMed ID: 11083769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human secretory immune response to streptococcal M protein. Identification of a secretory IgA epitope in the exposed conserved region.
    Yoshinaga M; Miyata K; Fischetti VA
    Adv Exp Med Biol; 1997; 418():913-5. PubMed ID: 9331797
    [No Abstract]   [Full Text] [Related]  

  • 11. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.
    Hayman WA; Toth I; Flinn N; Scanlon M; Good MF
    Immunol Cell Biol; 2002 Apr; 80(2):178-87. PubMed ID: 11940119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells.
    Fluckiger U; Jones KF; Fischetti VA
    Infect Immun; 1998 Mar; 66(3):974-9. PubMed ID: 9488384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of group A streptococcal isolates from tropical Australia with high prevalence of rheumatic fever: probing for signature sequences to identify members of the family of serotype 5.
    Hartas J; Goodfellow AM; Currie BJ; Sriprakash KS
    Microb Pathog; 1995 May; 18(5):345-54. PubMed ID: 7476099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
    Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
    J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.
    Jones KF; Fischetti VA
    J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitopes of streptococcal M proteins shared with cardiac myosin.
    Dale JB; Beachey EH
    J Exp Med; 1985 Aug; 162(2):583-91. PubMed ID: 2410530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic epitope mapping of the M24 protein of Streptococcus pyogenes: implications for serodiagnosis of rheumatic fever.
    Norton RE; Heuzenroeder M; Manning PA
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):267-71. PubMed ID: 9116645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral and mucosal delivery of a novel multi-epitope M protein-based group A streptococcal vaccine construct: investigation of immunogenicity in mice.
    Dunn LA; McMillan DJ; Batzloff M; Zeng W; Jackson DC; Upcroft JA; Upcroft P; Olive C
    Vaccine; 2002 Jun; 20(21-22):2635-40. PubMed ID: 12034087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.